Growth Metrics

Baxter International (BAX) Revenue (2016 - 2024)

Baxter International (BAX) has disclosed Revenue for 16 consecutive years, with $2.8 billion as the latest value for Q4 2024.

  • On a quarterly basis, Revenue rose 0.88% to $2.8 billion in Q4 2024 year-over-year; TTM through Sep 2025 was $2.8 billion, a 74.06% decrease, with the full-year FY2025 number at $11.2 billion, up 5.72% from a year prior.
  • Revenue was $2.8 billion for Q4 2024 at Baxter International, up from $2.7 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $3.7 billion in Q4 2022 to a low of $2.4 billion in Q1 2023.
  • A 5-year average of $3.0 billion and a median of $2.8 billion in 2020 define the central range for Revenue.
  • Peak YoY movement for Revenue: soared 30.22% in 2022, then crashed 31.39% in 2023.
  • Baxter International's Revenue stood at $3.2 billion in 2020, then decreased by 9.59% to $2.9 billion in 2021, then skyrocketed by 30.22% to $3.7 billion in 2022, then fell by 27.13% to $2.7 billion in 2023, then grew by 0.88% to $2.8 billion in 2024.
  • Per Business Quant, the three most recent readings for BAX's Revenue are $2.8 billion (Q4 2024), $2.7 billion (Q3 2024), and $2.7 billion (Q2 2024).